SCHEMBL4667374

SCHEMBL4667374

Nc1ccc(Nc2cccc(NCCO)n2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FCGR3B O75015 1/20 0.50
FCGR1A P12314 1/20 0.50
FCGR2A P12318 1/20 0.50
KDM4E B2RXH2 3/20 0.46
MAPT P10636 3/20 0.46
MEN1 O00255 1/20 0.46
ALPG P10696 1/20 0.46
RAB9A P51151 1/20 0.46
KMT2A Q03164 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
RECQL P46063 1/20 0.44
MCL1 Q07820 1/20 0.44
EGFR P00533 1/20 0.42
KCNH3 Q9ULD8 1/20 0.40
ALDH1A1 P00352 2/20 0.40
CYP2C19 P33261 2/20 0.40
POLB P06746 1/20 0.40
GAA P10253 1/20 0.40
CYP2D6 P10635 1/20 0.40
KDM6B O15054 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2175149 0.81 ALDH1A1 (0.58) KDM4EMAPTMEN1RAB9AKMT2A
SCHEMBL2176931 0.80 SCN9A (0.50) KDM4EMAPTMEN1ALPGRAB9A
SCHEMBL4665674 0.78 KCNH2 (0.46) KDM4EMAPTMEN1ALPGRAB9A
SCHEMBL1099121 0.76 KDM4E (0.46) KDM4EMAPTRAB9ARECQLMCL1
SCHEMBL29221782 0.76 MAPT (0.50) FCGR3BFCGR1AFCGR2AKDM4EMAPT
SCHEMBL4666258 0.75 MAPT (0.53) KDM4EMAPTMEN1ALPGRAB9A
SCHEMBL5200594 0.75 MAPT (0.39) FCGR3BFCGR1AFCGR2AKDM4EMAPT
SCHEMBL4665629 0.74 SCN9A (0.61) KDM4EMAPTMEN1ALPGRAB9A
SCHEMBL33766 0.73 APP (0.48) FCGR3BFCGR1AFCGR2AMAPTMEN1
SCHEMBL2178048 0.73 MERTK (0.56) KDM4EMAPTMEN1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1982749-B1 Novel hair colouring compositions for use in oxidative hair dyeing PROCTER & GAMBLE (US) 2013-04-17 EP claimed
EP-1982749-A2 Novel hair colouring compositions for use in oxidative hair dyeing The Procter and Gamble Company (US) 2008-10-22 EP claimed
US-7303592-B2 Hair coloring compositions for use in oxidative hair dyeing THE PROCTER & GAMBLE COMPANY (US) 2007-12-04 US claimed
EP-1855644-A2 HAIR COLORING COMPOSITIONS FOR USE IN OXIDATIVE HAIR DYEING The Procter and Gamble Company (US) 2007-11-21 EP claimed
WO-2006099115-A2 HAIR COLORING COMPOSITIONS FOR USE IN OXIDATIVE HAIR DYEING THE PROCTER & GAMBLE COMPANY (US) 2006-09-21 WO claimed
US-20050188480-A1 Novel hair coloring compositions for use in oxidative hair dyeing WELLA OPERATIONS US, LLC 2005-09-01 US claimed
EP-1982749-B1 Novel hair colouring compositions for use in oxidative hair dyeing PROCTER & GAMBLE (US) 2013-04-17 EP disclosed
EP-1982749-A2 Novel hair colouring compositions for use in oxidative hair dyeing The Procter and Gamble Company (US) 2008-10-22 EP disclosed
EP-1982748-A2 Novel hair colouring compositions for use in oxidative hair dyeing The Procter & Gamble (US) 2008-10-22 EP disclosed
US-7303592-B2 Hair coloring compositions for use in oxidative hair dyeing THE PROCTER & GAMBLE COMPANY (US) 2007-12-04 US disclosed
US-20050188480-A1 Novel hair coloring compositions for use in oxidative hair dyeing WELLA OPERATIONS US, LLC 2005-09-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050188480-A1 Novel hair coloring compositions for use in oxidative hair dyeing COXFA4L2, TYR, GPX4 FCGR3B 4419/4885FCGR1A 4649/4885FCGR2A 4516/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.